Amyloidosis is a rare protein-related condition that occurs when your body produces too many amyloid proteins, causing damage to your organs and tissues. Amyloid proteins are a type of protein ...

Immix Biopharma (IMMX) announced that the U.S. FDA has granted RMAT designation to sterically-optimized CAR-T NXC-201 for the treatment of ...

Chiefs Hall of Honor member Art Still is a proud foot soldier in the Amyloidosis Army, a nonprofit he started hoping to ...

Alnylam’s (ALNY) treatment of transthyretin-mediated amyloidosis, or ATTR amyloidosis, was granted FDA orphan designation, according to a post ...

Several case reports and retrospective cohort studies have described a marginal benefit with the use of internal cardioverter defibrillators in patients with cardiac amyloidosis. Detection of ...

H.C. Wainwright maintained its optimistic stance on Immix Biopharma , Inc. (NASDAQ:IMMX), with analyst Robert Burns reiterating a Buy rating and a $7.00 price target on the company's shares. Currently ...

While healthy transthyretin moves hormones through blood and spinal fluid, misfolded versions of the protein form dangerous clumps in the heart and along nerves-triggering a progressive and fatal ...

These insights could drive the development of new drugs to treat transthyretin amyloidosis, a progressive and fatal disease.

Amvuttra (vutrisiran) is a follow-up to Alnylam's earlier RNA interference (RNAi) ATTR amyloidosis therapy Onpattro (patisiran), which was cleared by NICE for NHS use in 2019, but offers a simpler ...

The European Commission has granted marketing authorization in the European Union (EU) for acoramidis, under the brand name ...

However, only two related conditions are associated with the simultaneous presence of Bence Jones proteinuria and heavy albuminuria: renal AL amyloidosis and LCDD. [20] It is not uncommon for ...